Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 8,702,125 | 8,244,000 | 8,915,764 | 7,744,000 | 8,002,000 |
| Cost of Goods | 1,724,230 | 1,752,000 | N/A | N/A | 1,760,000 |
| Gross Profit | 6,977,890 | 6,492,000 | 8,915,764 | 7,744,000 | 7,124,000 |
| Operating Expenses | 4,062,290 | 3,805,000 | 0 | 0 | 4,147,000 |
| Operating Income | 2,915,835 | 2,687,000 | 8,915,764 | 7,744,000 | 2,095,000 |
| Interest Expense | 59,900 | 55,000 | 0 | 0 | 61,000 |
| Other Income | 191,015 | 3,000 | 0 | 0 | 1,077,000 |
| Pre-tax Income | 3,046,950 | 2,635,000 | 8,915,764 | 7,744,000 | 3,111,000 |
| Income Tax | 853,210 | 712,000 | N/A | N/A | 871,000 |
| Net Income Continuous | 2,193,745 | 1,915,654 | 1,470,755 | 1,227,000 | 1,928,400 |
| Net Income | $2,193,745 | $1,915,654 | $1,470,755 | $1,227,000 | $1,928,400 |
| EPS Basic Total Ops | 0.98 | 0.83 | 0.63 | 0.53 | 0.81 |
| EPS Basic Continuous Ops | 0.97 | 0.82 | 0.62 | 0.53 | 0.81 |
| EPS Diluted Total Ops | 0.98 | 0.83 | 0.63 | 0.53 | 0.81 |
| EPS Diluted Continuous Ops | 0.97 | 0.82 | 0.62 | 0.53 | 0.81 |
| EBITDA(a) | $2,915,835 | $2,687,000 | $8,915,764 | $7,744,000 | $2,095,000 |